PubRank

R Burgos-Vargas

Author PubWeight™ 92.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000 29.03
2 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011 4.78
3 The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009 4.37
4 ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2005 4.31
5 The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009 3.32
6 A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol 1999 2.62
7 The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010 2.27
8 Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) 2006 1.55
9 Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2009 1.42
10 Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis 2001 1.25
11 Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2007 1.18
12 Features of spondyloarthritis around the world. Rheum Dis Clin North Am 1998 1.13
13 Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003 1.11
14 Validation of a Spanish version of the Childhood Health Assessment Questionnaire. J Rheumatol 1997 1.11
15 Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2005 1.09
16 A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis 2002 1.03
17 Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2006 1.02
18 An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis 2006 1.02
19 Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis 2002 0.99
20 Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol 1998 0.98
21 Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis 1998 0.98
22 Intradermal tophi in gout: a case-control study. J Rheumatol 1999 0.97
23 Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis Rheum 1999 0.97
24 Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 2002 0.93
25 Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) 2001 0.90
26 Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 2009 0.89
27 The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis 1997 0.88
28 TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin Exp Rheumatol 2002 0.88
29 Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol 1995 0.88
30 Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum 2009 0.87
31 Severe tophaceous gout. Characterization of low socioeconomic level patients from México. Clin Exp Rheumatol 2006 0.87
32 Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) 2000 0.87
33 HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol 2005 0.86
34 Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol 2014 0.85
35 Update on functional assessment tools. J Rheumatol Suppl 2000 0.84
36 Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients. Clin Exp Rheumatol 2009 0.83
37 HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol 1997 0.83
38 Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006 0.83
39 Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol 1995 0.82
40 Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol 1997 0.82
41 Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol 2000 0.81
42 [Juvenile ankylosing spondylitis: clinical characteristics in 41 patients]. Bol Med Hosp Infant Mex 1985 0.81
43 Antibodies to peptidoglycan in juvenile onset ankylosing spondylitis and pauciarticular onset juvenile arthritis associated with chronic iridocyclitis. J Rheumatol 1986 0.81
44 IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients. Scand J Rheumatol 2002 0.80
45 Association of HLA DRB1 alleles with juvenile idiopathic arthritis in Mexicans. Clin Exp Rheumatol 2010 0.80
46 Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann Rheum Dis 2010 0.80
47 The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol 2010 0.80
48 Illness trajectories in Mexican children with juvenile idiopathic arthritis and their parents. Rheumatology (Oxford) 2006 0.79
49 Anterior spinal flexion in healthy Mexican children. J Rheumatol 1985 0.79
50 Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 2009 0.78
51 Assessment of quality of life in children with rheumatic disease. J Rheumatol 1999 0.78
52 Antibody pattern and other criteria for diagnosis and classification in PSS. J Rheumatol 1988 0.78
53 Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Ann Rheum Dis 2002 0.78
54 The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001 0.78
55 Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis 2004 0.77
56 Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect. Drugs 1988 0.77
57 A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand J Rheumatol 2012 0.77
58 [The qualitative approach in health: an alternative to clinical research in rheumatic diseases]. Reumatol Clin 2008 0.77
59 Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid. J Clin Pathol 2007 0.77
60 Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J Rheumatol 1998 0.77
61 Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb Pathog 2000 0.77
62 Novel concepts of severity mechanisms in ankylosing spondylitis. J Rheumatol 2001 0.75
63 Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2010 0.75
64 Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout. J Clin Rheumatol 2000 0.75
65 [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study]. Rev Invest Clin 1984 0.75
66 [Axial involvement in juvenile ankylosing spondylitis]. Bol Med Hosp Infant Mex 1988 0.75
67 Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase. Rev Latinoam Microbiol 1997 0.75
68 Systemic features and early prognostic factors in Hispanic and non-Hispanic children from the United States of America and Mexico with systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 2008 0.75
69 Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms. J Rheumatol 1988 0.75
70 Uveitis of juvenile ankylosing spondylitis. J Rheumatol 1988 0.75
71 [Clinical study of dermato/polymyositis with onset in childhood]. Bol Med Hosp Infant Mex 1987 0.75
72 [Recognition and diagnosis of juvenile ankylosing spondylitis: clinical analysis and comparative study of juvenile rheumatoid arthritis]. Bol Med Hosp Infant Mex 1988 0.75
73 Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases. Reumatol Clin 2008 0.75